Thromb Haemost 2005; 93(03): 401-402
DOI: 10.1055/s-0037-1616567
Editorial Focus
Schattauer GmbH

Genetic variation in the fibrinogen gene cluster

Moniek P. M. de Maat
1   Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands
› Author Affiliations
Further Information

Publication History

Received 27 January 2005

Accepted after revision 28 January 2005

Publication Date:
14 December 2017 (online)

 

 
  • References

  • 1 Koenig W. Fibrin(ogen) in cardiovascular disease: an update. Thromb Haemost 2003; 89: 601-9.
  • 2 Naito M, Hayashi T, Kuzuya M. et al. Effects of fibrinogen and fibrin on the migration of vascular smooth muscle cells in vitro. Atherosclerosis 1990; 83: 9-14.
  • 3 Lou XJ, Boonmark NW, Horrigan FT. et al. Fibrinogen deficiency reduces vascular accumulation of apolipoprotein(a) and development of atherosclerosis in apolipoprotein(a) transgenic mice. Proc Natl Acad Sci U S A 1998; 95: 12591-5.
  • 4 de Maat MP. Effects of diet, drugs, and genes on plasma fibrinogen levels. Ann N Y Acad Sci 2001; 936: 509-21.
  • 5 de Maat MP, Bladbjerg EM, Hjelmborg JB. et al. Genetic influence on inflammation variables in the elderly. Arterioscler Thromb Vasc Biol 2004; 24: 2168-73.
  • 6 Green FR. Fibrinogen polymorphisms and atherothrombotic disease. Ann N Y Acad Sci 2001; 936: 549-59.
  • 7 Maghzal GJ, Brennan SO, George PM. Fibrinogen B beta polymorphisms do not directly contribute to an altered in vitro clot structure in humans. Thromb Haemost 2003; 90: 1021-8.
  • 8 Standeven KF, Grant PJ, Carter AM. et al. Functional analysis of the fibrinogen A α Thr312Ala polymorphism: effects on fibrin structure and function. Circulation 2003; 107: 2326-30.
  • 9 Carter AM, Catto AJ, Kohler HP. et al. alpha-fibrinogen Thr312Ala polymorphism and venous thromboembolism. Blood 2000; 96: 1177-9.
  • 10 Yu S, Sher B, Kudryk B. et al. Fibrinogen precursors. Order of assembly of fibrinogen chains. J Biol Chem 1984; 259: 10574-81.
  • 11 Humphries SE, Cook M, Dubowitz M. et al. Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations. Lancet 1987; 1: 1452-5.
  • 12 Redman CM, Xia H. Fibrinogen biosynthesis. Assembly, intracellular degradation, and association with lipid synthesis and secretion. Ann N Y Acad Sci 2001; 936: 480-95.
  • 13 Yang Q, Tofler GH, Cupples LA. et al. A genomewide search for genes affecting circulating fibrinogen levels in the Framingham Heart Study. Thromb Res 2003; 110: 57-64.
  • 14 van der Bom JG, de Maat MP, Bots ML. et al. Elevated plasma fibrinogen: cause or consequence of cardiovascular disease?. Arterioscler Thromb Vasc Biol 1998; 18: 621-5.
  • 15 Lane DA, Grant PJ. Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood 2000; 95: 1517-32.
  • 16 Mannila MN, Eriksson P, Lundman P. et al. Contribution of haplotypes accross the fibrinogen gene cluster to variation in risk of myocardial infarction. Thromb Haemost 2005; 93: 570-7.
  • 17 Iso H, Folsom AR, Winkelmann JC. et al. Polymorphisms of the beta fibrinogen gene and plasma fibrinogen concentration in Caucasian and Japanese population samples. Thromb Haemost 1995; 73: 106-11.
  • 18 de Maat MP, de Knijff P, Green FR. et al. Genderrelated association between beta-fibrinogen genotype and plasma fibrinogen levels and linkage disequilibrium at the fibrinogen locus in Greenland Inuit. Arterioscler Thromb Vasc Biol 1995; 15: 856-60.
  • 19 www.hapmap.org .